Rv0129c: fbpCRv0340Rv0341: iniBRv0342: iniARv0343: iniCRv1483: mabARv1484: inhARv1854c: ndhRv1592cRv1772Rv1908c: katG1909c: furARv2242: srm R homologRv2243: fabDRv2245: kasARv2247: accD6Rv2427A: oxyRRv2428: ahpCRv2846c: efpARv3139: fadE24Rv3566c: nhoARv3795: embB

Rv1908c

More about Rv1908c on    TBDB.org

More about Rv1908c on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv1908c: Codons 480 to 499: 5 mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Baker LV AAC 2005 CGT/AGT 1450 484 Arg/Ser 1998 United Kingdom Directed Oligonucleotide array, Sequencing Whole gene H,HS,HE,HSE,MDR ratio>=4 Resistance ratio method 202/378 1/0 - -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 GGT/GTT 1454 485 Gly/Val - - - - - - - - - - -
Marttila HJ AAC 1996 G/C 1464 488 Lys/Asn 1989-1995 Finland PCR, Sequencing. Whole gene H >1ug/ml Disk elution method. 17/19 1/0 katG Gln295STOP -
Baker LV AAC 2005 CGC/TGC 1469 490 Arg/Cys 1998 United Kingdom Directed Oligonucleotide array, Sequencing Whole gene H,HS,HE,HSE,MDR ratio>=4 Resistance ratio method 202/378 1/0 - -
Lavender C AAC 2005 GGC/TGC 1471 491 Gly/Cys 2001-2003 Australia Multiplex allele specific PCR assay Whole gene H 0.4 ug/ml BACTEC MGIT960 method 52/104 1/0 - -

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator